nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addition of recommendations for the use of recombinant human thrombomodulin to the “Expert consensus for the treatment of disseminated intravascular coagulation in Japan”
|
Wada, H. |
|
2014 |
134 |
4 |
p. 924-925 2 p. |
artikel |
2 |
Antithrombin-resistant prothrombin Yukuhashi mutation also causes thrombomodulin resistance in fibrinogen clotting but not in protein C activation
|
Takagi, Yuki |
|
2014 |
134 |
4 |
p. 914-917 4 p. |
artikel |
3 |
Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice
|
Kaatz, Scott |
|
2014 |
134 |
4 |
p. 807-813 7 p. |
artikel |
4 |
Bleeding and non-bleeding phenotypes in patients with GGCX gene mutations
|
Watzka, Matthias |
|
2014 |
134 |
4 |
p. 856-865 10 p. |
artikel |
5 |
Clinical Decision Rules and D-dimer in Venous Thromboembolism: Current controversies and future research priorities
|
Rodger, Marc A. |
|
2014 |
134 |
4 |
p. 763-768 6 p. |
artikel |
6 |
Cognitive dysfunctions and cerebral microbleeds in adult patients with haemophilia A: A clinical and MRI pilot-study
|
Zanon, Ezio |
|
2014 |
134 |
4 |
p. 851-855 5 p. |
artikel |
7 |
Development of Aptamer oligonucleotides as Anticoagulants and Antithrombotics for Cardiovascular Diseases: Current Status
|
Li, Weibin |
|
2014 |
134 |
4 |
p. 769-773 5 p. |
artikel |
8 |
Direct oral anticoagulants in the treatment of acute venous thromboembolism: A systematic review and meta-analysis
|
Gómez-Outes, Antonio |
|
2014 |
134 |
4 |
p. 774-782 9 p. |
artikel |
9 |
Editorial Board
|
|
|
2014 |
134 |
4 |
p. IFC- 1 p. |
artikel |
10 |
Effects of fibrinogen and platelet supplementation on clot formation and platelet aggregation in blood samples from cardiac surgery patients
|
Shams Hakimi, Caroline |
|
2014 |
134 |
4 |
p. 895-900 6 p. |
artikel |
11 |
Efficacy of postoperative anticoagulation therapy with enoxaparin for portal vein thrombosis after hepatic resection in patients with liver cancer
|
Yamashita, Yo-ichi |
|
2014 |
134 |
4 |
p. 826-831 6 p. |
artikel |
12 |
Ex vivo reversal of the anticoagulant effects of edoxaban
|
Halim, Abdel-Baset |
|
2014 |
134 |
4 |
p. 909-913 5 p. |
artikel |
13 |
Frequency of thrombotic risk factors in Chinese familial Budd-Chiari Syndrome
|
Zhang, Peijin |
|
2014 |
134 |
4 |
p. 926-927 2 p. |
artikel |
14 |
Genetic and non-genetic factors responsible for antiplatelet effects of clopidogrel in Japanese patients undergoing coronary stent implantation: An algorithm to predict on-clopidogrel platelet reactivity
|
Miura, Go |
|
2014 |
134 |
4 |
p. 877-883 7 p. |
artikel |
15 |
Global platelet hyperreactivity and elevated C-reactive protein levels predict long term mortality in STEMI patients
|
Marcucci, Rossella |
|
2014 |
134 |
4 |
p. 884-888 5 p. |
artikel |
16 |
Increased activation of blood coagulation in pregnant women with the Factor V Leiden mutation
|
Kjellberg, Ulla |
|
2014 |
134 |
4 |
p. 837-845 9 p. |
artikel |
17 |
Kidney transplant recipients receiving mTOR inhibitors experienced twice as many thrombotic events: A single cohort observational study
|
Musetti, Claudio |
|
2014 |
134 |
4 |
p. 928-930 3 p. |
artikel |
18 |
Low molecular weight heparin in management and prevention of portal vein thrombosis
|
Lisman, Ton |
|
2014 |
134 |
4 |
p. 761-762 2 p. |
artikel |
19 |
Measuring the activity of apixaban and rivaroxaban with rotational thrombelastometry
|
Adelmann, Dieter |
|
2014 |
134 |
4 |
p. 918-923 6 p. |
artikel |
20 |
Nut consumption and the risk of coronary artery disease: A dose–response meta-analysis of 13 prospective studies
|
Ma, Ling |
|
2014 |
134 |
4 |
p. 790-794 5 p. |
artikel |
21 |
On the monitoring of dabigatran treatment in “real life” patients with atrial fibrillation
|
Skeppholm, Mika |
|
2014 |
134 |
4 |
p. 783-789 7 p. |
artikel |
22 |
Overuse of Compression Ultrasound for Patients with Lower Extremity Cellulitis
|
Gunderson, Craig G. |
|
2014 |
134 |
4 |
p. 846-850 5 p. |
artikel |
23 |
Padua prediction score and thrombin generation in hospitalized medical patients
|
Saliba, Walid |
|
2014 |
134 |
4 |
p. 803-806 4 p. |
artikel |
24 |
Platelet activation biomarkers in Berkeley sickle cell mice and the response to prasugrel
|
Ohno, Kousaku |
|
2014 |
134 |
4 |
p. 889-894 6 p. |
artikel |
25 |
Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: A randomized trial
|
Schulman, S. |
|
2014 |
134 |
4 |
p. 814-818 5 p. |
artikel |
26 |
Salvianolic acid B inhibits platelets as a P2Y12 antagonist and PDE inhibitor: Evidence from clinic to laboratory
|
Liu, Lei |
|
2014 |
134 |
4 |
p. 866-876 11 p. |
artikel |
27 |
Serum soluble CD40 Ligand levels are associated with severity and mortality of brain trauma injury patients
|
Lorente, Leonardo |
|
2014 |
134 |
4 |
p. 832-836 5 p. |
artikel |
28 |
Treatment patterns of venous thromboembolism in a real-world population: The Q-VTE study cohort
|
Tagalakis, Vicky |
|
2014 |
134 |
4 |
p. 795-802 8 p. |
artikel |
29 |
Two novel mutations in the fibrinogen γ nodule
|
Kotlín, Roman |
|
2014 |
134 |
4 |
p. 901-908 8 p. |
artikel |
30 |
Validity of standard gamble estimated quality of life in acute venous thrombosis
|
Hogg, Kerstin |
|
2014 |
134 |
4 |
p. 819-825 7 p. |
artikel |